Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation

(PresseBox) ( San Diego, Ca, )
Ambry Genetics and RainDance Technologies today jointly announced at the Annual CHI Next Generation Sequencing Conference in San Diego, CA their partnership utilizing the RDT 1000 for sequence enrichment and resequencing validation. A global leader for genetic testing and next generation sequencing services, Ambry Genetics is a CLIA certified and CAP accredited Diagnostic and Genomic Services company providing solutions to both clinical and research clients.

"Ambry Genetics has dedicated its investments in technology for the benefit of the scientific and research community," said Ardy Arianpour, Director of Business Development. "We are motivated to provide our Diagnostic, Genomic and Research customers with the best solutions for their projects, and the addition of RainDance's RDT 1000 adds a sequenceenrichment offering while providing an option for customers that are in need of highthroughput targeted sequencing with a high level of coverage, completeness and speed."

Researchers can utilize the RDT 1000 and Ambry Genetics Next Generation Services to either greatly reduce study time, or to improve study quality by running more samples in the same time within the same experimental budget.

"We're pleased to partner with Ambry Genetics to provide our microdroplet PCRbased solution in conjunction with Ambry's genetic testing and next generation sequencing services " said Chris McNary, Chief Commercial Officer of, RainDance Technologies. "PCR is the gold standard for sequence enrichment and allows for highresolution analysis of rare genetic variations, a focus area of Ambry Genetics' customers". Ambry is currently offering RainDance's sequence enrichment solution and may add two new applications, Methyl-Seq and Ultra-Deep Resequencing in the second half of 2010, further enhancing their customers' ability to understand the origins and pathways of complex diseases."

About RainDance Technologies, Inc. - www.raindancetech.com

RainDance Technologies' proprietary technology platform delivers exquisite sensitivity and data quality that inspires scientists, researchers, and clinicians to rethink the way they design experiments, approach discovery, or conduct clinical diagnostics. The core RainStorm technology empowers customers to conduct de novo science in an ultrahigh throughput, simple, flexible, and lowcost manner. RainDance's commercial products include instruments and highvalue consumables and reagents for sequence enrichment for nextgeneration sequencing, ultradeep sequencing, and methylation analysis. RainDance sells directly in the U.S. and in Europe, and is building distribution networks in Europe and Asia-Pacific. RainDance Technologies, with headquarters in Lexington, Massachusetts, and a European sales office in the United Kingdom, has approximately 70 employees worldwide. For more information, please visit www.raindancetech.com.

RainStorm is a trademark of RainDance Technologies, Inc.
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.